Package 82442-321-71

{"route": ["ORAL"], "spl_id": "1d1f2bed-e173-402f-875a-af1a73c87d96", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["H0G9379FGK", "5QZO15J2Z8", "NBZ3QY004S"], "rxcui": ["283641"], "spl_set_id": ["8e925e57-9036-4658-bf07-578e22675af8"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (82442-321-71)", "package_ndc": "82442-321-71", "marketing_start_date": "20250108"}], "brand_name": "UP AND UP DUAL ACTION ACID REDUCER ANTACID", "product_id": "82442-321_1d1f2bed-e173-402f-875a-af1a73c87d96", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "82442-321", "generic_name": "famotidine, calcium carbonate and magnesium hydroxide", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "UP AND UP DUAL ACTION ACID REDUCER ANTACID", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/1"}, {"name": "FAMOTIDINE", "strength": "10 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "165 mg/1"}], "application_number": "ANDA077355", "marketing_category": "ANDA", "marketing_start_date": "20250108", "listing_expiration_date": "20261231"}